David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Among the biggest losers in Friday’s early trading are InfoBlox (Nasdaq: BLOX), Pandora (NYSE: P) and Mattress Firm Holdings (Nasdaq: MFRM). Whenever a company says its plans to ramp up internal spending to meet future growth plans, it can mean… Read More
As you can see below, the CurrencyShares Euro Trust (NYSE: FXE) fell from $134 in March to $120 in August. A recovery to the halfway point of that decline at $127 would likely send desperate short sellers running for cover. A larger objective targets a move above $130. Read More
It’s often said that what is past is prologue, and that’s usually true when it comes to financial markets. And when we look at past performance for the markets in September, we get a gloomy sense of prologue. That’s because, historically, September is the worst-performing month of the year for… Read More
When it comes to investing biotech stocks, it’s wise to focus on companies that have completed much of their drug development work. The closer a company gets to the finish line in the clinical-testing process, the less chance that a drug will fail — taking the company’s stock down sharply.#-ad_banner-#… Read More
If you’re an income investor who strives for stable, high-yielding assets, then you should be looking at master limited partnerships (MLPs). Particularly right now, MLPs can be terrific investments — their yields are exceptional, averaging nearly 7% and well above the average yields for utility stocks (about 4%),… Read More
Stocks trading for less than $5 have a special attraction to investors. Because of their cheap prices, smaller investors are able to buy a larger number of shares, while providing a better return opportunity than stocks in their full valuation. In… Read More
Among the biggest losers in Friday’s early trading are VeriFone Systems (NYSE: PAY) and OCZ Technologies (NYSE: OCZ). “Please swipe here” is a phrase you’ve heard at countless checkout counters, and when you look down, you’ve often seen the name VeriFone. The company’s card-swiping machines are so ubiquitous in… Read More
Among the biggest winners in Thursday’s early trading are The Men’s Wearhouse (NYSE: MW) and Merge Healthcare (Nasdaq: MRGE). Suiting up Fast on the heels of a solid quarterly report last week from men’s clothier Jos. A Bank (NYSE: JOSB) rival, The… Read More
You’ve likely heard of this valuation method countless times: The price-to-earnings (P/E) ratio that analysts use to compare a stock’s current share price to its per-share earnings. By this measure, stocks may… Read More
There has been a break in the news cycle as Europe has been quiet for a few weeks, but that is about to change. The next summit of European leaders is scheduled for mid-October, but politicians are already posturing so there could be market-moving news before then.#-ad_banner-#… Read More
